Drug Discovery and Development Based on Quantitative Systems Pharmacology (QSP)
Home
About UPDDI
Programs
Liver Diseases
Metastatic Cancers
Neurodegenerative Diseases
Projects
Acute Kidney Injury
Autosomal Dominant Leukodystrophy
Malignant Gliomas
Mcm2-7 Replicative Helicase
MAP Kinase Phosphatases
MPS Data Center
SARS-CoV-2
Triose phosphate Isomerase
White Adipose Tissue
Technical Strengths
Discovery Technologies
Chemistry/Medicinal Chemistry
Early Safety Assessment
Computational Chemistry
Computational Biology
Preclinical ADME/Tox & Rodent Efficacy
Collaborations
Environment
Facilities
Discovery Technology
Chemistry/Medicinal Chemistry
Computational Biology & Chemistry
Zebrafish Facility
Preclinical Resources
Drug Discovery Education
People
Director/Associate Directors
Internal Advisory Board
External Advisory Board
Leadership Faculty
Core Faculty
Team Members
News + Events
Publications
EveAnalytics (formerly BioSystics-AP)
Contact Us
Positions Available
Giving
UPDDI IT Policies
MENU
MENU
Home
About UPDDI
Programs
Liver Diseases
Metastatic Cancers
Neurodegenerative Diseases
Projects
Acute Kidney Injury
Autosomal Dominant Leukodystrophy
Malignant Gliomas
Mcm2-7 Replicative Helicase
MAP Kinase Phosphatases
MPS Data Center
SARS-CoV-2
Triose phosphate Isomerase
White Adipose Tissue
Technical Strengths
Discovery Technologies
Chemistry/Medicinal Chemistry
Early Safety Assessment
Computational Chemistry
Computational Biology
Preclinical ADME/Tox & Rodent Efficacy
Collaborations
Environment
Facilities
Discovery Technology
Chemistry/Medicinal Chemistry
Computational Biology & Chemistry
Zebrafish Facility
Preclinical Resources
Drug Discovery Education
People
Director/Associate Directors
Internal Advisory Board
External Advisory Board
Leadership Faculty
Core Faculty
Team Members
News + Events
Publications
EveAnalytics (formerly BioSystics-AP)
Contact Us
Positions Available
Giving
UPDDI IT Policies
Last modified
by ddiadm -
10 months
ago
Mark Schurdak, PhD
Director of Operations, Drug Discovery Institute, Associate Professor of Computational and Systems Biology
412-648-3090
Mes234@pitt.edu
Last modified
by ddiadm -
10 months
ago
Andrew Stern, PhD
Director of Novel Therapeutics, Drug Discovery Institute, Associate Professor of Computational and Systems Biology
412-648-9200
Sternam@pitt.edu
Last modified
by ddiadm -
10 months
ago
Lawrence Vernetti, PhD
Director of Early Drug Safety, Drug Discovery Institute, Associate Professor of Computational and Systems Biology
412-624-5425
Vernetti@pitt.edu
Last modified
by ddiadm -
10 months
ago
Albert Gough, PhD
Group Leader of Informatics and Cell Analysis, Drug Discovery Institute, Associate Professor of Computational and Systems Biology
412-648-9200
gough@pitt.edu
Last modified
by ddiadm -
10 months
ago
Andreas Vogt, PhD
Group Leader Small Organism Discovery and Projects, Drug Discovery Institute, Associate Professor of Computational and Systems Biology
412-383-5856
avogt@pitt.edu
Last modified
by ddiadm -
10 months
ago
Jan H. Beumer, PharmD, PhD, DAB
Professor of Pharmaceutical Sciences; Co-Director of UPMC Hillman Cancer Center Cancer Pharmacokinetics and Pharmacodynamics Facility (CPPF)
412-623-3216
beumerjh@upmc.edu
Click for more info
Last modified
by ddiadm -
10 months
ago
John Stewart Maier, PhD MD
Assistant Professor, Co-Director of Innovation Core, Clinical Translational Science Institute (CTSI); Director of Pitt Innovation Challenge, CTSI
412-383-2377
jsmaier@pitt.edu
Click for more info
Last modified
by ddiadm -
10 months
ago
Xiang-Qun (Sean) Xie, MD, PhD, EMBA
Associate Dean for Research Innovation, Professor, Pharmaceutical Sciences
412-383-5276
xix15@pitt.edu
Click for more info
Post navigation
WordPress Image Lightbox Plugin